{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T02:29:26Z","timestamp":1781404166833,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s12028-008-9087-6","type":"journal-article","created":{"date-parts":[[2008,3,31]],"date-time":"2008-03-31T10:45:12Z","timestamp":1206960312000},"page":"103-107","source":"Crossref","is-referenced-by-count":50,"title":["The Coagulopathy of Acute Liver Failure and Implications for Intracranial Pressure Monitoring"],"prefix":"10.1007","volume":"9","author":[{"given":"Santiago J.","family":"Munoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Rajender Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Acute Liver Failure Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,1]]},"reference":[{"key":"9087_CR1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/lt.500050102","volume":"5","author":"F Schiodt","year":"1999","unstructured":"Schiodt F, Atillasoy E, Shakil O, Schiff E, Caldwell C, Kowdley K, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl. 1999;5:29\u201334.","journal-title":"Liver Transpl."},{"key":"9087_CR2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","volume":"137","author":"G Ostapowicz","year":"2002","unstructured":"Ostapowicz G, Fontana R, Schiodt F, Larson A, Davern T, Han S, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Int Med. 2002;137:947\u201354.","journal-title":"Ann Int Med."},{"key":"9087_CR3","first-page":"63","volume":"19","author":"R Clark","year":"1973","unstructured":"Clark R, Rake MO, Flute PT, Williams R. Coagulation abnormalities in acute liver failure; pathogenetic and therapeutic implications. Scand J Gastroent (Suppl). 1973;19:63\u201370.","journal-title":"Scand J Gastroent (Suppl)."},{"key":"9087_CR4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1055\/s-2007-1007253","volume":"16","author":"SP Pereira","year":"1996","unstructured":"Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Sem Liver Dis. 1996;16:403\u201314.","journal-title":"Sem Liver Dis."},{"key":"9087_CR5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cld.2006.08.006","volume":"10","author":"JF Trotter","year":"2006","unstructured":"Trotter JF. Coagulation abnormalities in patients who have liver disease. Clin Liver Dis. 2006;10:665\u201378.","journal-title":"Clin Liver Dis."},{"key":"9087_CR6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000103655","volume":"24","author":"T Lisman","year":"2007","unstructured":"Lisman T, Leebeek F. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg. 2007;24:250\u20138.","journal-title":"Dig Surg."},{"key":"9087_CR7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-2008-1040599","volume":"6","author":"JG O\u2019Grady","year":"1986","unstructured":"O\u2019Grady JG, Langley PG, Sisola L, Aladort L, Williams R. Coagulopathy of fulminant hepatic failure. Sem Liver Dis. 1986;6:159\u201363.","journal-title":"Sem Liver Dis."},{"key":"9087_CR8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0168-8278(02)00199-X","volume":"37","author":"T Lisman","year":"2002","unstructured":"Lisman T, Leebeek FWG, de Groot P. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37:280\u20137.","journal-title":"J Hepatol."},{"key":"9087_CR9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hep.21303","volume":"44","author":"SH Caldwell","year":"2006","unstructured":"Caldwell SH, Hoffman M, Lisman T, Macik B, Northup P, Reddy K, et al. Coagulation disorders and hemostasis in liver disease: physiopathology and critical assessment of current management. Hepatology. 2006;44:1039\u201346.","journal-title":"Hepatology."},{"key":"9087_CR10","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1097\/01.CCM.0000287592.94554.5F","volume":"35","author":"RT Stravitz","year":"2007","unstructured":"Stravitz RT, Kramer AH, Davern T, Shaikh O, Caldwell S, Mehta R, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007;35:2498\u2013508.","journal-title":"Crit Care Med."},{"key":"9087_CR11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/gut.16.8.617","volume":"16","author":"BG Gazzard","year":"1975","unstructured":"Gazzard BG, Henderson JM, Williams R. Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut. 1975;16:617\u201320.","journal-title":"Gut."},{"key":"9087_CR12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/gut.14.10.805","volume":"14","author":"B Rueff","year":"1973","unstructured":"Rueff B, Benhamou JP. Acute hepatic necrosis and fulminant hepatic failure. Gut. 1973;14:805\u201314.","journal-title":"Gut."},{"key":"9087_CR13","first-page":"282","volume":"3","author":"C Trey","year":"1970","unstructured":"Trey C, Davidson C. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282\u201398.","journal-title":"Prog Liver Dis."},{"key":"9087_CR14","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0016-5085(16)34599-1","volume":"100","author":"S Munoz","year":"1991","unstructured":"Munoz S. Prothrombin time in fulminant hepatic failure. Gastroenterology. 1991;100:1480\u20139.","journal-title":"Gastroenterology."},{"key":"9087_CR15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","volume":"41","author":"A Tripodi","year":"2005","unstructured":"Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005: 41:553\u20138.","journal-title":"Hepatology."},{"key":"9087_CR16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1538-7836.2006.01887.x","volume":"4","author":"JC Reverter","year":"2006","unstructured":"Reverter JC. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes. J Thromb Haemostasis. 2006;4:717\u201320.","journal-title":"J Thromb Haemostasis."},{"key":"9087_CR17","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.510240613","volume":"24","author":"A Robert","year":"1996","unstructured":"Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology. 1996;24:1392\u20134.","journal-title":"Hepatology."},{"key":"9087_CR18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(77)92055-4","volume":"1","author":"BR MacDougall","year":"1977","unstructured":"MacDougall BR, Bailey RJ, Williams R. H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials. Lancet. 1977;1:617\u20139.","journal-title":"Lancet."},{"key":"9087_CR19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0140-6736(93)90016-A","volume":"341","author":"AT Blei","year":"1993","unstructured":"Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet. 1993;341:157\u20138.","journal-title":"Lancet."},{"key":"9087_CR20","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/lt.20625","volume":"11","author":"J Vaquero","year":"2005","unstructured":"Vaquero J, Fontana RJ, Larson A, Bass N, Davern T, Shakil O, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl. 2005;11:1581\u20139.","journal-title":"Liver Transpl."},{"key":"9087_CR21","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/hep.1840180614","volume":"18","author":"BW Donaldson","year":"1993","unstructured":"Donaldson BW, Gopinath R, Wanless I, Phillips M, Cameron R, Roberts E, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology. 1993;18:1370\u20136.","journal-title":"Hepatology."},{"key":"9087_CR22","first-page":"219","volume":"176","author":"E Mor","year":"1993","unstructured":"Mor E, Jennings L, Gonwa TA, Holman M, Gibbs J, Solomon H, et al. The impact of operative bleeding on outcome in transplantation of the liver. Surg Gyn Obst. 1993;176:219\u201327.","journal-title":"Surg Gyn Obst."},{"key":"9087_CR23","first-page":"817","volume":"68","author":"JG O\u2019Grady","year":"1988","unstructured":"O\u2019Grady JG, Alexander GJ, Thick M, Potter D, Calne R, Williams R. Outcome of orthotopic liver transplantation in the aetiological and clinical variants of acute liver failure. Q J Med. 1988;68:817\u201324.","journal-title":"Q J Med."},{"key":"9087_CR24","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510270421","volume":"27","author":"W Bernal","year":"1998","unstructured":"Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology. 1998;27:1050\u20135.","journal-title":"Hepatology."},{"key":"9087_CR25","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/hep.1840210420","volume":"21","author":"J Devlin","year":"1995","unstructured":"Devlin J, Wendon J, Heaton N, Tan K, Williams R. Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure. Hepatolog Wily. 1995;21:1018\u201324.","journal-title":"Hepatology."},{"key":"9087_CR26","first-page":"666","volume":"237","author":"DG Farmer","year":"2003","unstructured":"Farmer DG, Anselmo DM, Ghobrial RM, Yersiz H, McDiarmid S, Cao C, et al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg. 2003;237:666\u201375.","journal-title":"Ann Surg."},{"key":"9087_CR27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-2007-1007368","volume":"13","author":"S Mu\u00f1oz","year":"1993","unstructured":"Mu\u00f1oz S. Difficult management problems in fulminant hepatic failure. Sem Liver Dis. 1993;13:395\u2013413.","journal-title":"Sem Liver Dis."},{"key":"9087_CR28","doi-asserted-by":"crossref","unstructured":"Munoz S, Stravitz R, Gabriel D. Coagulopathy of acute liver failure. Clin Liver Dis. 2008; in press.","DOI":"10.1016\/j.cld.2008.10.001"},{"key":"9087_CR29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/jlts.2003.50017","volume":"9","author":"V Shami","year":"2003","unstructured":"Shami V, Caldwell S, Hespenheide E. Recombinant activated factor VII for the coagulopathy of fulminant hepatic failure compared with conventional therapy. Liver Transpl. 2003;9:138\u201343.","journal-title":"Liver Transplant."},{"issue":"4","key":"9087_CR30","doi-asserted-by":"crossref","first-page":"550A","DOI":"10.1016\/S0270-9139(03)80848-0","volume":"38","author":"D Quan","year":"2003","unstructured":"Quan D, Bass N, Hirose R. The effect of recombinant factor VIIa and fresh frozen plasma on the INR in patients with acute and chronic liver failure. Hepatology. 2003;38(4):550A.","journal-title":"Hepatology."},{"key":"9087_CR31","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/lt.20447","volume":"11","author":"R Porte","year":"2005","unstructured":"Porte R, Caldwell S. The role of recombinant factor VIIa in liver transplantation. Liver Transpl. 2005;11:872\u20134.","journal-title":"Liver Transplant."}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-008-9087-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-008-9087-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-008-9087-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:06:43Z","timestamp":1559426803000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-008-9087-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["9087"],"URL":"https:\/\/doi.org\/10.1007\/s12028-008-9087-6","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,1]]}}}